
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) and Qiagen (NYSE:QGEN – Get Free Report) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent [...]
The Lincolnian Online
Original source

